Immunohistochemical detection of p140(trkA) and p75(LNGFR) neurotrophin receptors in neuroblastoma

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 57-64

  Dominici, Carlo ^a   Nicotra, Maria Rita ^b   Alemà, Stefano ^b   Bosman, Cesare ^c   Castello, Manuel A ^a   Donfrancesco, Alberto ^d   Gallo, Pietro ^c   McDowell, Heather ^e   Natali, Pier Giorgio ^f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Immunohistochemistry; Nerve growth factor; Neuroblastoma; Neurotrophin receptors; Neurotrophins

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; NEUROTROPHIN RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NORTHERN BLOTTING; PROGNOSIS; RELIABILITY; TREATMENT OUTCOME; CELL CULTURE; CHEMISTRY; GENETICS; IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; BLOTTING, NORTHERN; CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030614764     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005781313596     Document Type: Article

References (53)

1. Evans AE, Gerson J, Schnaufer L: Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44: 49-54, 1976
2. Woods WG, Lemieux B, Tuchman M: Neuroblastoma represents distinct clinical-biologic entities - A review and perspective from the Quebec Neuroblastoma Screening Project. Pediatrics 89: 114-118, 1992
3. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS: Neurotrophic factors - From molecule to man. Trends Neurosci 17: 182-190, 1994
4. Götz R, Köster R, Winkler C, Raulf F, Lottspeich F, Schartl M, Thoenen H: Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372: 266-269, 1994
5. Chao MV: Neurotrophin receptors - A window into neuronal differentiation. Neuron 9: 583-593, 1992
6. Meakin SO, Shooter EM: The nerve growth factor family of receptors. Trends Neurosci 15: 323-331, 1992
7. Barbacid M: Nerve growth factor - A tale of two receptors. Oncogene 8: 2033-2042, 1993
8. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor definies an unusual family of cellular and viral proteins. Science 248: 1019-1023, 1990
9. Feinstein DL, Larhammer D: Identification of a conserved protein motif in a group of growth factor receptors. FEBS Lett 272: 7-11, 1990
10. trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem 269: 6884-6891, 1994
11. Chao MV, Hempstead BL: p75 and Trk - A two-receptor system. Trends Neurosci 18: 321-326, 1995
12. Jing S, Tapley P, Barbacid M: Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9: 1067-1079, 1992
13. Stemple DL, Mahanthappa NK, Anderson DJ: Basic FGF induces neuronal differentiation, cell division, and NGF dependence in chromaffin cells - A sequence of events in sympathetic development. Neuron 1: 517-525, 1988
14. Yan Q, Johnson EM Jr: A quantitative study of the developmental expression of nerve growth factor (NGF) receptor in rats. Dev Biol 121: 139-148, 1987
15. Heuer JG, Fatemie-Nainie S, Wheeler EF, Bothwell M: Structure and developmental expression of the chicken NGF receptor. Dev Biol 137: 287-304, 1990
16. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM Jr: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829-844, 1988
17. 2+. Proc Natl Acad Sci USA 88: 3892-3896, 1991
18. Kumar S: Nerve growth factor and neuroblastoma. J Histochem Cytochem 36: 1359-1360, 1988
19. Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM: Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ 1: 421-428, 1990
20. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC: Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85: 377-384, 1993
21. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854, 1993
22. Kogner P, Barbany G, Dominici C, Castello MA, Raschellà G, Persson H: Coexpression of messenger RNA for trk protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53: 2044-2050, 1993
23. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, Rizzetti MG, Mondellini P, De Bernardi B, Di Martino D, Garaventa A, Brisigotti M, Tonini GP: trk and ret proto-oncogene expression in human neuroblastoma specimens - High-frequency of trk expression in non-advanced stages. Int J Cancer 54: 540-545, 1993
24. trk nerve growth factor (NGF) receptor. Med Pediatr Oncol 23: 210, 1994 (abstr)
25. Dominici C, Nicotra MR, Digiesi G, McDowell H, Alemà S, Padula A, Gargano N, Donfrancesco A, Castello MA, Natali PG: Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma. Eur J Cancer 31A: 444-446, 1995
26. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson AD J, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477, 1993
27. Raschellà G, Negroni A, Giubilei C, Romeo A, Ferrari S, Castello MA, Dominici C: Transcription of N-myc and proliferation-related genes is linked in human neuroblastoma. Cancer Lett 56: 45-51, 1991
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
29. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M: Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 9: 24-33, 1989
30. Johnson D, Lanahan AA, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell MA, Chao MV: Expression and structure of the human NGF receptor. Cell 47: 545-554, 1986
31. Ross AH, Grob P, Bothwell M, Elder DE, Ernst CS, Marano N, Ghrist BFD, Slemp CC, Herlyn M, Atkinson B, Koprowski H: Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 81: 6681-6685, 1984
32. Preisler HD, Raza A: The role of emerging technologies in the diagnosis and staging of neoplastic diseases. Cancer 69: 1520-1526, 1992
33. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma - A Pediatric Oncology Group study. J Clin Oncol 9: 581-591, 1991
34. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116, 1985
35. Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM: Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52: 1780-1785, 1992
36. Srivatsan ES, Ying KL, Seeger RC: Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chrom Cancer 7: 32-37, 1993
37. Caron H: Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 24: 215-221, 1995
38. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM: Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 759-767, 1994
39. Brodeur GM: Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer 31A: 505-510, 1995
40. Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu X, Lee CP, Evans AE: Expression of TRK-A, TRK-B and TRK-C in human neuroblastoma. Proceedings of the 'Third Workshop on Biochemistry of Neuroectodermal Tumours', Rome, June 12-14; p. 32, 1995 (abstr)
41. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM: Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55: 1792-1797, 1995
42. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8: 855-865, 1993
43. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC: Expression of stem cell factor and c-kit in human neuroblastoma. Blood 84: 3465-3472, 1994
44. Tanaka T, Slamon DJ, Shimada H, Shimoda H, Fujisawa T, Ida N, Seeger RC: A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis - A retrospective study of 103 cases. Cancer 68: 1296-1302, 1991
45. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G: Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143: 1543-1550, 1993
46. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D: CD44H expression by human neuroblastoma cells - Relation to MYCN amplification and lineage differentiation. Cancer Res 54: 4238-4242, 1994
47. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1: 249-255, 1995
48. Dominici C, Kogner P, Kouvidou H, Hedborg F, Donfrancesco A, Castello MA, Falkmer UG: Image and flow cytometric DNA measurements in neuroblastoma. Proc Am Assoc Cancer Res 34: 38, 1993 (abstr)
49. Perosio PM, Brooks JJ: Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. Am J Pathol 132: 152-160, 1988
50. Chesa PG, Rettig WJ, Thomson TM, Old LJ, Melamed MR: Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem 36: 383-389, 1988
51. Christiansen H, Christiansen NM, Wagner F, Altmannsberger M, Lampert F: Neuroblastoma - Inverse relationship between expression of N-myc and NGF-r. Oncogene 5: 437-440, 1990
52. Baker DL, Molenaar WM, Trojanowski JQ, Evans AE, Ross AH, Rorke LB, Packer RJ, Lee VMY, Pleasure D: Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. Am J Pathol 139: 115-122, 1991
53. Donovan MJ, Hempstead BL, Horvath C, Chao MV, Schofield D: Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am J Pathol 143: 1560-1567, 1993